nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—Back pain—Ezetimibe—atherosclerosis	0.00123	0.00178	CcSEcCtD
Acamprosate—Muscle spasms—Ezetimibe—atherosclerosis	0.00122	0.00177	CcSEcCtD
Acamprosate—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00122	0.00177	CcSEcCtD
Acamprosate—Mental disorder—Simvastatin—atherosclerosis	0.00122	0.00177	CcSEcCtD
Acamprosate—Tremor—Lovastatin—atherosclerosis	0.00122	0.00176	CcSEcCtD
Acamprosate—Visual impairment—Pravastatin—atherosclerosis	0.00122	0.00176	CcSEcCtD
Acamprosate—Ill-defined disorder—Lovastatin—atherosclerosis	0.00121	0.00174	CcSEcCtD
Acamprosate—Flatulence—Simvastatin—atherosclerosis	0.0012	0.00173	CcSEcCtD
Acamprosate—Tinnitus—Niacin—atherosclerosis	0.00119	0.00173	CcSEcCtD
Acamprosate—Dysgeusia—Simvastatin—atherosclerosis	0.00119	0.00172	CcSEcCtD
Acamprosate—Angioedema—Lovastatin—atherosclerosis	0.00119	0.00172	CcSEcCtD
Acamprosate—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00118	0.00171	CcSEcCtD
Acamprosate—Anaemia—Ezetimibe—atherosclerosis	0.00118	0.0017	CcSEcCtD
Acamprosate—Tinnitus—Pravastatin—atherosclerosis	0.00118	0.0017	CcSEcCtD
Acamprosate—Malaise—Lovastatin—atherosclerosis	0.00117	0.00169	CcSEcCtD
Acamprosate—Muscle spasms—Simvastatin—atherosclerosis	0.00117	0.00169	CcSEcCtD
Acamprosate—Vertigo—Lovastatin—atherosclerosis	0.00117	0.00169	CcSEcCtD
Acamprosate—Angioedema—Ezetimibe—atherosclerosis	0.00116	0.00168	CcSEcCtD
Acamprosate—Leukopenia—Lovastatin—atherosclerosis	0.00116	0.00168	CcSEcCtD
Acamprosate—Chills—Niacin—atherosclerosis	0.00115	0.00166	CcSEcCtD
Acamprosate—Malaise—Ezetimibe—atherosclerosis	0.00115	0.00166	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00114	0.00165	CcSEcCtD
Acamprosate—Tremor—Simvastatin—atherosclerosis	0.00114	0.00165	CcSEcCtD
Acamprosate—Alopecia—Niacin—atherosclerosis	0.00113	0.00164	CcSEcCtD
Acamprosate—Chills—Pravastatin—atherosclerosis	0.00113	0.00164	CcSEcCtD
Acamprosate—Insomnia—Rosuvastatin—atherosclerosis	0.00113	0.00164	CcSEcCtD
Acamprosate—Ill-defined disorder—Simvastatin—atherosclerosis	0.00113	0.00163	CcSEcCtD
Acamprosate—Palpitations—Ezetimibe—atherosclerosis	0.00113	0.00163	CcSEcCtD
Acamprosate—Paraesthesia—Rosuvastatin—atherosclerosis	0.00112	0.00162	CcSEcCtD
Acamprosate—Anaemia—Simvastatin—atherosclerosis	0.00112	0.00162	CcSEcCtD
Acamprosate—Malnutrition—Niacin—atherosclerosis	0.00112	0.00161	CcSEcCtD
Acamprosate—Alopecia—Pravastatin—atherosclerosis	0.00112	0.00161	CcSEcCtD
Acamprosate—Cough—Ezetimibe—atherosclerosis	0.00111	0.00161	CcSEcCtD
Acamprosate—Angioedema—Simvastatin—atherosclerosis	0.00111	0.00161	CcSEcCtD
Acamprosate—Arthralgia—Lovastatin—atherosclerosis	0.00111	0.0016	CcSEcCtD
Acamprosate—Chest pain—Lovastatin—atherosclerosis	0.00111	0.0016	CcSEcCtD
Acamprosate—Myalgia—Lovastatin—atherosclerosis	0.00111	0.0016	CcSEcCtD
Acamprosate—Anxiety—Lovastatin—atherosclerosis	0.0011	0.00159	CcSEcCtD
Acamprosate—Dyspepsia—Rosuvastatin—atherosclerosis	0.0011	0.00159	CcSEcCtD
Acamprosate—Hypertension—Ezetimibe—atherosclerosis	0.0011	0.00159	CcSEcCtD
Acamprosate—Flatulence—Niacin—atherosclerosis	0.0011	0.00159	CcSEcCtD
Acamprosate—Malaise—Simvastatin—atherosclerosis	0.0011	0.00158	CcSEcCtD
Acamprosate—Tension—Niacin—atherosclerosis	0.00109	0.00158	CcSEcCtD
Acamprosate—Discomfort—Lovastatin—atherosclerosis	0.00109	0.00158	CcSEcCtD
Acamprosate—Vertigo—Simvastatin—atherosclerosis	0.00109	0.00158	CcSEcCtD
Acamprosate—Leukopenia—Simvastatin—atherosclerosis	0.00109	0.00157	CcSEcCtD
Acamprosate—Myalgia—Ezetimibe—atherosclerosis	0.00108	0.00157	CcSEcCtD
Acamprosate—Chest pain—Ezetimibe—atherosclerosis	0.00108	0.00157	CcSEcCtD
Acamprosate—Arthralgia—Ezetimibe—atherosclerosis	0.00108	0.00157	CcSEcCtD
Acamprosate—Nervousness—Niacin—atherosclerosis	0.00108	0.00157	CcSEcCtD
Acamprosate—Flatulence—Pravastatin—atherosclerosis	0.00108	0.00157	CcSEcCtD
Acamprosate—Dry mouth—Lovastatin—atherosclerosis	0.00108	0.00156	CcSEcCtD
Acamprosate—Tension—Pravastatin—atherosclerosis	0.00108	0.00156	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00108	0.00156	CcSEcCtD
Acamprosate—Dysgeusia—Pravastatin—atherosclerosis	0.00108	0.00156	CcSEcCtD
Acamprosate—Muscle spasms—Niacin—atherosclerosis	0.00107	0.00155	CcSEcCtD
Acamprosate—Discomfort—Ezetimibe—atherosclerosis	0.00107	0.00155	CcSEcCtD
Acamprosate—Pain—Rosuvastatin—atherosclerosis	0.00107	0.00155	CcSEcCtD
Acamprosate—Constipation—Rosuvastatin—atherosclerosis	0.00107	0.00155	CcSEcCtD
Acamprosate—Confusional state—Lovastatin—atherosclerosis	0.00107	0.00155	CcSEcCtD
Acamprosate—Nervousness—Pravastatin—atherosclerosis	0.00107	0.00154	CcSEcCtD
Acamprosate—Dry mouth—Ezetimibe—atherosclerosis	0.00106	0.00153	CcSEcCtD
Acamprosate—Anaphylactic shock—Lovastatin—atherosclerosis	0.00106	0.00153	CcSEcCtD
Acamprosate—Muscle spasms—Pravastatin—atherosclerosis	0.00106	0.00153	CcSEcCtD
Acamprosate—Infection—Lovastatin—atherosclerosis	0.00105	0.00152	CcSEcCtD
Acamprosate—Confusional state—Ezetimibe—atherosclerosis	0.00105	0.00152	CcSEcCtD
Acamprosate—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00104	0.0015	CcSEcCtD
Acamprosate—Thrombocytopenia—Lovastatin—atherosclerosis	0.00104	0.0015	CcSEcCtD
Acamprosate—Chest pain—Simvastatin—atherosclerosis	0.00103	0.0015	CcSEcCtD
Acamprosate—Myalgia—Simvastatin—atherosclerosis	0.00103	0.0015	CcSEcCtD
Acamprosate—Arthralgia—Simvastatin—atherosclerosis	0.00103	0.0015	CcSEcCtD
Acamprosate—Infection—Ezetimibe—atherosclerosis	0.00103	0.00149	CcSEcCtD
Acamprosate—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00103	0.00149	CcSEcCtD
Acamprosate—Anxiety—Simvastatin—atherosclerosis	0.00103	0.00149	CcSEcCtD
Acamprosate—Tremor—Pravastatin—atherosclerosis	0.00103	0.00149	CcSEcCtD
Acamprosate—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00102	0.00148	CcSEcCtD
Acamprosate—Discomfort—Simvastatin—atherosclerosis	0.00102	0.00148	CcSEcCtD
Acamprosate—Angioedema—Niacin—atherosclerosis	0.00102	0.00147	CcSEcCtD
Acamprosate—Ill-defined disorder—Pravastatin—atherosclerosis	0.00102	0.00147	CcSEcCtD
Acamprosate—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00102	0.00147	CcSEcCtD
Acamprosate—Anaemia—Pravastatin—atherosclerosis	0.00102	0.00147	CcSEcCtD
Acamprosate—Anorexia—Lovastatin—atherosclerosis	0.00101	0.00146	CcSEcCtD
Acamprosate—Skin disorder—Ezetimibe—atherosclerosis	0.00101	0.00146	CcSEcCtD
Acamprosate—Angioedema—Pravastatin—atherosclerosis	0.001	0.00145	CcSEcCtD
Acamprosate—Vertigo—Niacin—atherosclerosis	0.001	0.00145	CcSEcCtD
Acamprosate—Syncope—Niacin—atherosclerosis	0.001	0.00145	CcSEcCtD
Acamprosate—Confusional state—Simvastatin—atherosclerosis	0.001	0.00145	CcSEcCtD
Acamprosate—Leukopenia—Niacin—atherosclerosis	0.000999	0.00144	CcSEcCtD
Acamprosate—Urticaria—Rosuvastatin—atherosclerosis	0.000994	0.00144	CcSEcCtD
Acamprosate—Anaphylactic shock—Simvastatin—atherosclerosis	0.000992	0.00143	CcSEcCtD
Acamprosate—Malaise—Pravastatin—atherosclerosis	0.000991	0.00143	CcSEcCtD
Acamprosate—Abdominal pain—Rosuvastatin—atherosclerosis	0.000989	0.00143	CcSEcCtD
Acamprosate—Vertigo—Pravastatin—atherosclerosis	0.000987	0.00143	CcSEcCtD
Acamprosate—Palpitations—Niacin—atherosclerosis	0.000986	0.00143	CcSEcCtD
Acamprosate—Infection—Simvastatin—atherosclerosis	0.000985	0.00142	CcSEcCtD
Acamprosate—Leukopenia—Pravastatin—atherosclerosis	0.000983	0.00142	CcSEcCtD
Acamprosate—Loss of consciousness—Niacin—atherosclerosis	0.000981	0.00142	CcSEcCtD
Acamprosate—Cough—Niacin—atherosclerosis	0.000974	0.00141	CcSEcCtD
Acamprosate—Thrombocytopenia—Simvastatin—atherosclerosis	0.000971	0.0014	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000966	0.0014	CcSEcCtD
Acamprosate—Insomnia—Lovastatin—atherosclerosis	0.000959	0.00139	CcSEcCtD
Acamprosate—Cough—Pravastatin—atherosclerosis	0.000959	0.00139	CcSEcCtD
Acamprosate—Paraesthesia—Lovastatin—atherosclerosis	0.000952	0.00138	CcSEcCtD
Acamprosate—Arthralgia—Niacin—atherosclerosis	0.00095	0.00137	CcSEcCtD
Acamprosate—Myalgia—Niacin—atherosclerosis	0.00095	0.00137	CcSEcCtD
Acamprosate—Hypertension—Pravastatin—atherosclerosis	0.000948	0.00137	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000947	0.00137	CcSEcCtD
Acamprosate—Anorexia—Simvastatin—atherosclerosis	0.000945	0.00137	CcSEcCtD
Acamprosate—Dyspnoea—Lovastatin—atherosclerosis	0.000945	0.00137	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000943	0.00136	CcSEcCtD
Acamprosate—Insomnia—Ezetimibe—atherosclerosis	0.00094	0.00136	CcSEcCtD
Acamprosate—Arthralgia—Pravastatin—atherosclerosis	0.000935	0.00135	CcSEcCtD
Acamprosate—Myalgia—Pravastatin—atherosclerosis	0.000935	0.00135	CcSEcCtD
Acamprosate—Chest pain—Pravastatin—atherosclerosis	0.000935	0.00135	CcSEcCtD
Acamprosate—Paraesthesia—Ezetimibe—atherosclerosis	0.000934	0.00135	CcSEcCtD
Acamprosate—Dyspepsia—Lovastatin—atherosclerosis	0.000933	0.00135	CcSEcCtD
Acamprosate—Anxiety—Pravastatin—atherosclerosis	0.000932	0.00135	CcSEcCtD
Acamprosate—Dry mouth—Niacin—atherosclerosis	0.000929	0.00134	CcSEcCtD
Acamprosate—Dyspnoea—Ezetimibe—atherosclerosis	0.000927	0.00134	CcSEcCtD
Acamprosate—Discomfort—Pravastatin—atherosclerosis	0.000924	0.00134	CcSEcCtD
Acamprosate—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000922	0.00133	CcSEcCtD
Acamprosate—Decreased appetite—Lovastatin—atherosclerosis	0.000922	0.00133	CcSEcCtD
Acamprosate—Dyspepsia—Ezetimibe—atherosclerosis	0.000915	0.00132	CcSEcCtD
Acamprosate—Anaphylactic shock—Niacin—atherosclerosis	0.000911	0.00132	CcSEcCtD
Acamprosate—Pain—Lovastatin—atherosclerosis	0.000907	0.00131	CcSEcCtD
Acamprosate—Constipation—Lovastatin—atherosclerosis	0.000907	0.00131	CcSEcCtD
Acamprosate—Confusional state—Pravastatin—atherosclerosis	0.000904	0.00131	CcSEcCtD
Acamprosate—Decreased appetite—Ezetimibe—atherosclerosis	0.000904	0.00131	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000903	0.00131	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000898	0.0013	CcSEcCtD
Acamprosate—Asthenia—Rosuvastatin—atherosclerosis	0.000898	0.0013	CcSEcCtD
Acamprosate—Insomnia—Simvastatin—atherosclerosis	0.000897	0.0013	CcSEcCtD
Acamprosate—Anaphylactic shock—Pravastatin—atherosclerosis	0.000896	0.0013	CcSEcCtD
Acamprosate—Shock—Niacin—atherosclerosis	0.000896	0.0013	CcSEcCtD
Acamprosate—Infection—Pravastatin—atherosclerosis	0.000891	0.00129	CcSEcCtD
Acamprosate—Paraesthesia—Simvastatin—atherosclerosis	0.00089	0.00129	CcSEcCtD
Acamprosate—Pain—Ezetimibe—atherosclerosis	0.000889	0.00129	CcSEcCtD
Acamprosate—Constipation—Ezetimibe—atherosclerosis	0.000889	0.00129	CcSEcCtD
Acamprosate—Tachycardia—Niacin—atherosclerosis	0.000889	0.00129	CcSEcCtD
Acamprosate—Pruritus—Rosuvastatin—atherosclerosis	0.000885	0.00128	CcSEcCtD
Acamprosate—Skin disorder—Niacin—atherosclerosis	0.000884	0.00128	CcSEcCtD
Acamprosate—Dyspnoea—Simvastatin—atherosclerosis	0.000884	0.00128	CcSEcCtD
Acamprosate—Hyperhidrosis—Niacin—atherosclerosis	0.00088	0.00127	CcSEcCtD
Acamprosate—Thrombocytopenia—Pravastatin—atherosclerosis	0.000878	0.00127	CcSEcCtD
Acamprosate—Feeling abnormal—Lovastatin—atherosclerosis	0.000874	0.00126	CcSEcCtD
Acamprosate—Dyspepsia—Simvastatin—atherosclerosis	0.000873	0.00126	CcSEcCtD
Acamprosate—Anorexia—Niacin—atherosclerosis	0.000868	0.00126	CcSEcCtD
Acamprosate—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000867	0.00125	CcSEcCtD
Acamprosate—Hyperhidrosis—Pravastatin—atherosclerosis	0.000867	0.00125	CcSEcCtD
Acamprosate—Decreased appetite—Simvastatin—atherosclerosis	0.000862	0.00125	CcSEcCtD
Acamprosate—Feeling abnormal—Ezetimibe—atherosclerosis	0.000857	0.00124	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000856	0.00124	CcSEcCtD
Acamprosate—Diarrhoea—Rosuvastatin—atherosclerosis	0.000856	0.00124	CcSEcCtD
Acamprosate—Anorexia—Pravastatin—atherosclerosis	0.000855	0.00124	CcSEcCtD
Acamprosate—Hypotension—Niacin—atherosclerosis	0.000851	0.00123	CcSEcCtD
Acamprosate—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00085	0.00123	CcSEcCtD
Acamprosate—Pain—Simvastatin—atherosclerosis	0.000848	0.00123	CcSEcCtD
Acamprosate—Constipation—Simvastatin—atherosclerosis	0.000848	0.00123	CcSEcCtD
Acamprosate—Urticaria—Lovastatin—atherosclerosis	0.000842	0.00122	CcSEcCtD
Acamprosate—Body temperature increased—Lovastatin—atherosclerosis	0.000838	0.00121	CcSEcCtD
Acamprosate—Abdominal pain—Lovastatin—atherosclerosis	0.000838	0.00121	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00083	0.0012	CcSEcCtD
Acamprosate—Dizziness—Rosuvastatin—atherosclerosis	0.000827	0.0012	CcSEcCtD
Acamprosate—Urticaria—Ezetimibe—atherosclerosis	0.000826	0.00119	CcSEcCtD
Acamprosate—Insomnia—Niacin—atherosclerosis	0.000824	0.00119	CcSEcCtD
Acamprosate—Body temperature increased—Ezetimibe—atherosclerosis	0.000822	0.00119	CcSEcCtD
Acamprosate—Abdominal pain—Ezetimibe—atherosclerosis	0.000822	0.00119	CcSEcCtD
Acamprosate—Paraesthesia—Niacin—atherosclerosis	0.000818	0.00118	CcSEcCtD
Acamprosate—Feeling abnormal—Simvastatin—atherosclerosis	0.000817	0.00118	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000817	0.00118	CcSEcCtD
Acamprosate—Dyspnoea—Niacin—atherosclerosis	0.000812	0.00117	CcSEcCtD
Acamprosate—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000811	0.00117	CcSEcCtD
Acamprosate—Insomnia—Pravastatin—atherosclerosis	0.000811	0.00117	CcSEcCtD
Acamprosate—Somnolence—Niacin—atherosclerosis	0.000809	0.00117	CcSEcCtD
Acamprosate—Paraesthesia—Pravastatin—atherosclerosis	0.000805	0.00116	CcSEcCtD
Acamprosate—Dyspepsia—Niacin—atherosclerosis	0.000801	0.00116	CcSEcCtD
Acamprosate—Dyspnoea—Pravastatin—atherosclerosis	0.000799	0.00116	CcSEcCtD
Acamprosate—Decreased appetite—Niacin—atherosclerosis	0.000791	0.00114	CcSEcCtD
Acamprosate—Dyspepsia—Pravastatin—atherosclerosis	0.000789	0.00114	CcSEcCtD
Acamprosate—Rash—Rosuvastatin—atherosclerosis	0.000789	0.00114	CcSEcCtD
Acamprosate—Dermatitis—Rosuvastatin—atherosclerosis	0.000788	0.00114	CcSEcCtD
Acamprosate—Urticaria—Simvastatin—atherosclerosis	0.000788	0.00114	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Niacin—atherosclerosis	0.000786	0.00114	CcSEcCtD
Acamprosate—Body temperature increased—Simvastatin—atherosclerosis	0.000784	0.00113	CcSEcCtD
Acamprosate—Abdominal pain—Simvastatin—atherosclerosis	0.000784	0.00113	CcSEcCtD
Acamprosate—Headache—Rosuvastatin—atherosclerosis	0.000784	0.00113	CcSEcCtD
Acamprosate—Hypersensitivity—Lovastatin—atherosclerosis	0.000781	0.00113	CcSEcCtD
Acamprosate—Decreased appetite—Pravastatin—atherosclerosis	0.000779	0.00113	CcSEcCtD
Acamprosate—Pain—Niacin—atherosclerosis	0.000779	0.00113	CcSEcCtD
Acamprosate—Constipation—Pravastatin—atherosclerosis	0.000767	0.00111	CcSEcCtD
Acamprosate—Pain—Pravastatin—atherosclerosis	0.000767	0.00111	CcSEcCtD
Acamprosate—Hypersensitivity—Ezetimibe—atherosclerosis	0.000766	0.00111	CcSEcCtD
Acamprosate—Asthenia—Lovastatin—atherosclerosis	0.000761	0.0011	CcSEcCtD
Acamprosate—Pruritus—Lovastatin—atherosclerosis	0.00075	0.00108	CcSEcCtD
Acamprosate—Asthenia—Ezetimibe—atherosclerosis	0.000746	0.00108	CcSEcCtD
Acamprosate—Gastrointestinal pain—Niacin—atherosclerosis	0.000745	0.00108	CcSEcCtD
Acamprosate—Nausea—Rosuvastatin—atherosclerosis	0.000743	0.00107	CcSEcCtD
Acamprosate—Feeling abnormal—Pravastatin—atherosclerosis	0.000739	0.00107	CcSEcCtD
Acamprosate—Pruritus—Ezetimibe—atherosclerosis	0.000736	0.00106	CcSEcCtD
Acamprosate—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000733	0.00106	CcSEcCtD
Acamprosate—Hypersensitivity—Simvastatin—atherosclerosis	0.000731	0.00106	CcSEcCtD
Acamprosate—Diarrhoea—Lovastatin—atherosclerosis	0.000725	0.00105	CcSEcCtD
Acamprosate—Urticaria—Niacin—atherosclerosis	0.000723	0.00105	CcSEcCtD
Acamprosate—Abdominal pain—Niacin—atherosclerosis	0.00072	0.00104	CcSEcCtD
Acamprosate—Body temperature increased—Niacin—atherosclerosis	0.00072	0.00104	CcSEcCtD
Acamprosate—Urticaria—Pravastatin—atherosclerosis	0.000712	0.00103	CcSEcCtD
Acamprosate—Asthenia—Simvastatin—atherosclerosis	0.000711	0.00103	CcSEcCtD
Acamprosate—Diarrhoea—Ezetimibe—atherosclerosis	0.000711	0.00103	CcSEcCtD
Acamprosate—Abdominal pain—Pravastatin—atherosclerosis	0.000709	0.00102	CcSEcCtD
Acamprosate—Body temperature increased—Pravastatin—atherosclerosis	0.000709	0.00102	CcSEcCtD
Acamprosate—Pruritus—Simvastatin—atherosclerosis	0.000702	0.00101	CcSEcCtD
Acamprosate—Dizziness—Lovastatin—atherosclerosis	0.000701	0.00101	CcSEcCtD
Acamprosate—Dizziness—Ezetimibe—atherosclerosis	0.000688	0.000994	CcSEcCtD
Acamprosate—Diarrhoea—Simvastatin—atherosclerosis	0.000678	0.000981	CcSEcCtD
Acamprosate—Vomiting—Lovastatin—atherosclerosis	0.000674	0.000975	CcSEcCtD
Acamprosate—Hypersensitivity—Niacin—atherosclerosis	0.000671	0.00097	CcSEcCtD
Acamprosate—Rash—Lovastatin—atherosclerosis	0.000668	0.000967	CcSEcCtD
Acamprosate—Dermatitis—Lovastatin—atherosclerosis	0.000668	0.000966	CcSEcCtD
Acamprosate—Headache—Lovastatin—atherosclerosis	0.000664	0.000961	CcSEcCtD
Acamprosate—Vomiting—Ezetimibe—atherosclerosis	0.000661	0.000956	CcSEcCtD
Acamprosate—Hypersensitivity—Pravastatin—atherosclerosis	0.00066	0.000955	CcSEcCtD
Acamprosate—Dizziness—Simvastatin—atherosclerosis	0.000656	0.000948	CcSEcCtD
Acamprosate—Rash—Ezetimibe—atherosclerosis	0.000656	0.000948	CcSEcCtD
Acamprosate—Dermatitis—Ezetimibe—atherosclerosis	0.000655	0.000947	CcSEcCtD
Acamprosate—Asthenia—Niacin—atherosclerosis	0.000653	0.000945	CcSEcCtD
Acamprosate—Headache—Ezetimibe—atherosclerosis	0.000651	0.000942	CcSEcCtD
Acamprosate—Pruritus—Niacin—atherosclerosis	0.000644	0.000932	CcSEcCtD
Acamprosate—Asthenia—Pravastatin—atherosclerosis	0.000643	0.00093	CcSEcCtD
Acamprosate—Pruritus—Pravastatin—atherosclerosis	0.000634	0.000917	CcSEcCtD
Acamprosate—Vomiting—Simvastatin—atherosclerosis	0.00063	0.000912	CcSEcCtD
Acamprosate—Nausea—Lovastatin—atherosclerosis	0.00063	0.000911	CcSEcCtD
Acamprosate—Rash—Simvastatin—atherosclerosis	0.000625	0.000904	CcSEcCtD
Acamprosate—Dermatitis—Simvastatin—atherosclerosis	0.000625	0.000903	CcSEcCtD
Acamprosate—Diarrhoea—Niacin—atherosclerosis	0.000623	0.000901	CcSEcCtD
Acamprosate—Headache—Simvastatin—atherosclerosis	0.000621	0.000898	CcSEcCtD
Acamprosate—Nausea—Ezetimibe—atherosclerosis	0.000618	0.000893	CcSEcCtD
Acamprosate—Diarrhoea—Pravastatin—atherosclerosis	0.000613	0.000887	CcSEcCtD
Acamprosate—Dizziness—Niacin—atherosclerosis	0.000602	0.000871	CcSEcCtD
Acamprosate—Dizziness—Pravastatin—atherosclerosis	0.000593	0.000857	CcSEcCtD
Acamprosate—Nausea—Simvastatin—atherosclerosis	0.000589	0.000852	CcSEcCtD
Acamprosate—Vomiting—Niacin—atherosclerosis	0.000579	0.000837	CcSEcCtD
Acamprosate—Rash—Niacin—atherosclerosis	0.000574	0.00083	CcSEcCtD
Acamprosate—Dermatitis—Niacin—atherosclerosis	0.000574	0.00083	CcSEcCtD
Acamprosate—Headache—Niacin—atherosclerosis	0.00057	0.000825	CcSEcCtD
Acamprosate—Vomiting—Pravastatin—atherosclerosis	0.00057	0.000824	CcSEcCtD
Acamprosate—Rash—Pravastatin—atherosclerosis	0.000565	0.000817	CcSEcCtD
Acamprosate—Dermatitis—Pravastatin—atherosclerosis	0.000565	0.000817	CcSEcCtD
Acamprosate—Headache—Pravastatin—atherosclerosis	0.000562	0.000812	CcSEcCtD
Acamprosate—Nausea—Niacin—atherosclerosis	0.000541	0.000782	CcSEcCtD
Acamprosate—Nausea—Pravastatin—atherosclerosis	0.000532	0.00077	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—CCL3—atherosclerosis	0.000403	0.0013	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CCR2—atherosclerosis	0.000401	0.0013	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—EDNRA—atherosclerosis	0.000401	0.0013	CbGpPWpGaD
Acamprosate—GABRA1—Orphan transporters—APOB—atherosclerosis	0.000397	0.00129	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—F2—atherosclerosis	0.000392	0.00127	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—GHRL—atherosclerosis	0.000391	0.00127	CbGpPWpGaD
Acamprosate—GABRB3—Orphan transporters—PPARA—atherosclerosis	0.00039	0.00127	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000388	0.00126	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—PRKCG—atherosclerosis	0.000386	0.00125	CbGpPWpGaD
Acamprosate—GABRG2—Orphan transporters—PPARA—atherosclerosis	0.000383	0.00124	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000381	0.00123	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APOA4—atherosclerosis	0.000378	0.00122	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	0.000377	0.00122	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—PRKCG—atherosclerosis	0.000376	0.00122	CbGpPWpGaD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—ALB—atherosclerosis	0.000376	0.00122	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000372	0.0012	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—TNF—atherosclerosis	0.000371	0.0012	CbGpPWpGaD
Acamprosate—GRIN1—EPH-Ephrin signaling—MMP9—atherosclerosis	0.000366	0.00119	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000365	0.00118	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCR2—atherosclerosis	0.000364	0.00118	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—EDNRA—atherosclerosis	0.000364	0.00118	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IFNG—atherosclerosis	0.000363	0.00118	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—ESR2—atherosclerosis	0.000362	0.00117	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—MAPK3—atherosclerosis	0.000357	0.00116	CbGpPWpGaD
Acamprosate—GRIN2B—EPH-Ephrin signaling—MMP9—atherosclerosis	0.000357	0.00116	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—GHRL—atherosclerosis	0.000355	0.00115	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CCL2—atherosclerosis	0.00035	0.00113	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—MAPK3—atherosclerosis	0.000348	0.00113	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL4—atherosclerosis	0.000348	0.00113	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—PTGS2—atherosclerosis	0.000348	0.00113	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—PLG—atherosclerosis	0.000345	0.00112	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—KNG1—atherosclerosis	0.000343	0.00111	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—AGTR1—atherosclerosis	0.000341	0.0011	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—PRKCG—atherosclerosis	0.000339	0.0011	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—atherosclerosis	0.000339	0.0011	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—CXCL8—atherosclerosis	0.000337	0.00109	CbGpPWpGaD
Acamprosate—GABRA1—Orphan transporters—PPARA—atherosclerosis	0.000335	0.00109	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—atherosclerosis	0.000333	0.00108	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000333	0.00108	CbGpPWpGaD
Acamprosate—GRIN1—EPH-Ephrin signaling—VEGFA—atherosclerosis	0.000329	0.00107	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APOA2—atherosclerosis	0.000325	0.00105	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—TNF—atherosclerosis	0.000324	0.00105	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL1B—atherosclerosis	0.000324	0.00105	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—SPP1—atherosclerosis	0.000323	0.00105	CbGpPWpGaD
Acamprosate—GRIN2B—EPH-Ephrin signaling—VEGFA—atherosclerosis	0.00032	0.00104	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000319	0.00103	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.000318	0.00103	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—TNF—atherosclerosis	0.000316	0.00102	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—KNG1—atherosclerosis	0.000311	0.00101	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—UTS2—atherosclerosis	0.00031	0.00101	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AGTR1—atherosclerosis	0.00031	0.001	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—MMP9—atherosclerosis	0.000305	0.000989	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—APOB—atherosclerosis	0.000305	0.000988	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CX3CR1—atherosclerosis	0.000297	0.000964	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CASR—atherosclerosis	0.000297	0.000964	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—PRKCG—atherosclerosis	0.000296	0.000959	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000294	0.000952	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CX3CL1—atherosclerosis	0.000292	0.000945	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—atherosclerosis	0.000291	0.000942	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—EDN1—atherosclerosis	0.000289	0.000936	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000288	0.000935	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—PRKCG—atherosclerosis	0.000288	0.000935	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CCL5—atherosclerosis	0.000287	0.000929	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL10—atherosclerosis	0.000279	0.000906	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CNR2—atherosclerosis	0.000277	0.000896	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CXCL8—atherosclerosis	0.000276	0.000896	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—MMP3—atherosclerosis	0.000276	0.000894	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000275	0.000892	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PRKCG—atherosclerosis	0.000273	0.000883	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	0.00027	0.000874	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000266	0.000863	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—EDN1—atherosclerosis	0.000262	0.00085	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000261	0.000847	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCL5—atherosclerosis	0.00026	0.000844	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—ADIPOQ—atherosclerosis	0.00026	0.000842	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—MAPK3—atherosclerosis	0.000259	0.00084	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL1B—atherosclerosis	0.000259	0.000839	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—NFKB1—atherosclerosis	0.000257	0.000834	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—PPARA—atherosclerosis	0.000257	0.000833	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—PRKCG—atherosclerosis	0.000255	0.000825	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—ADIPOQ—atherosclerosis	0.000253	0.000821	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—MAPK8—atherosclerosis	0.000253	0.00082	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000252	0.000817	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TGFB1—atherosclerosis	0.000251	0.000815	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—NFKB1—atherosclerosis	0.000251	0.000813	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—PRKCG—atherosclerosis	0.00025	0.000811	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PRKCG—atherosclerosis	0.000248	0.000802	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—MAPK8—atherosclerosis	0.000247	0.000799	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VWF—atherosclerosis	0.000246	0.000799	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APOC3—atherosclerosis	0.000245	0.000794	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—LDLR—atherosclerosis	0.000243	0.000789	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	0.000241	0.000783	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—APOA1—atherosclerosis	0.000241	0.000782	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—AGT—atherosclerosis	0.00024	0.000777	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000239	0.000776	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL3—atherosclerosis	0.000238	0.000771	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000235	0.000762	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TNF—atherosclerosis	0.000235	0.000761	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—STAT3—atherosclerosis	0.000231	0.00075	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.00023	0.000747	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000229	0.000741	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NCF1—atherosclerosis	0.000228	0.000738	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000226	0.000733	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—STAT3—atherosclerosis	0.000226	0.000731	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—F2—atherosclerosis	0.000222	0.000718	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—MAPK3—atherosclerosis	0.000221	0.000716	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	0.000219	0.00071	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—PRKCG—atherosclerosis	0.000219	0.000708	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AGT—atherosclerosis	0.000218	0.000706	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—MAPK3—atherosclerosis	0.000215	0.000698	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EDNRA—atherosclerosis	0.000215	0.000697	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCR2—atherosclerosis	0.000215	0.000697	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CYBA—atherosclerosis	0.000214	0.000694	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000212	0.000687	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PARP1—atherosclerosis	0.00021	0.000679	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GHRL—atherosclerosis	0.00021	0.000679	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PLAT—atherosclerosis	0.00021	0.000679	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000206	0.000666	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—F2—atherosclerosis	0.000201	0.000652	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000198	0.000641	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—PRKCG—atherosclerosis	0.000195	0.000632	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—LPL—atherosclerosis	0.000193	0.000624	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CG—atherosclerosis	0.000193	0.000624	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—PRKCG—atherosclerosis	0.000192	0.000621	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—ALB—atherosclerosis	0.000191	0.000619	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL6—atherosclerosis	0.000189	0.000614	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—TNF—atherosclerosis	0.000188	0.000609	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—LPL—atherosclerosis	0.000188	0.000609	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KNG1—atherosclerosis	0.000184	0.000596	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CD36—atherosclerosis	0.000183	0.000593	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AGTR1—atherosclerosis	0.000183	0.000593	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP2—atherosclerosis	0.000181	0.000586	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCL2—atherosclerosis	0.000179	0.000581	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CD36—atherosclerosis	0.000178	0.000578	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PLG—atherosclerosis	0.000178	0.000577	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP2—atherosclerosis	0.000176	0.000572	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—CETP—atherosclerosis	0.000171	0.000553	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PPARA—atherosclerosis	0.00017	0.000551	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—NFKB1—atherosclerosis	0.00017	0.00055	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SOCS3—atherosclerosis	0.000169	0.000547	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—CETP—atherosclerosis	0.000168	0.000543	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—PRKCG—atherosclerosis	0.000168	0.000543	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MAPK8—atherosclerosis	0.000167	0.000541	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PPARA—atherosclerosis	0.000166	0.000538	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP3—atherosclerosis	0.000163	0.000528	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IGF2—atherosclerosis	0.000162	0.000526	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—LEP—atherosclerosis	0.000161	0.000523	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APOB—atherosclerosis	0.000158	0.00051	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—LEP—atherosclerosis	0.000157	0.00051	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CXCL8—atherosclerosis	0.000156	0.000506	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EDN1—atherosclerosis	0.000155	0.000502	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL5—atherosclerosis	0.000154	0.000498	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	0.000153	0.000495	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—STAT3—atherosclerosis	0.000153	0.000495	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL6—atherosclerosis	0.000152	0.000491	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—LPL—atherosclerosis	0.00015	0.000487	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.00015	0.000487	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—AKT1—atherosclerosis	0.000149	0.000483	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.000148	0.000479	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL1B—atherosclerosis	0.000147	0.000475	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—CETP—atherosclerosis	0.000146	0.000475	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PRKCG—atherosclerosis	0.000146	0.000474	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MAPK3—atherosclerosis	0.000146	0.000473	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—AKT1—atherosclerosis	0.000145	0.000471	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SPP1—atherosclerosis	0.000142	0.000462	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CXCL8—atherosclerosis	0.000142	0.00046	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PPARG—atherosclerosis	0.000141	0.000456	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—INS—atherosclerosis	0.000138	0.000447	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PPARG—atherosclerosis	0.000137	0.000444	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	0.000137	0.000443	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP9—atherosclerosis	0.000136	0.000441	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—INS—atherosclerosis	0.000134	0.000436	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP9—atherosclerosis	0.000133	0.00043	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PDGFB—atherosclerosis	0.000132	0.000427	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP2—atherosclerosis	0.000129	0.000418	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.000129	0.000418	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AGT—atherosclerosis	0.000129	0.000417	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—PLG—atherosclerosis	0.000128	0.000414	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—LEP—atherosclerosis	0.000126	0.000409	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APOE—atherosclerosis	0.000126	0.000409	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP2—atherosclerosis	0.000126	0.000408	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—PLG—atherosclerosis	0.000126	0.000407	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CAV1—atherosclerosis	0.000125	0.000405	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APOA1—atherosclerosis	0.000125	0.000404	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	0.000124	0.000402	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—VEGFA—atherosclerosis	0.000122	0.000396	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ESR1—atherosclerosis	0.00012	0.00039	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—VEGFA—atherosclerosis	0.000119	0.000386	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—F2—atherosclerosis	0.000119	0.000385	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.000118	0.000382	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.000116	0.000375	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MAPK3—atherosclerosis	0.000116	0.000374	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CG—atherosclerosis	0.000114	0.000369	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—APOB—atherosclerosis	0.000113	0.000366	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MAPK3—atherosclerosis	0.000113	0.000365	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—APOB—atherosclerosis	0.000111	0.00036	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—PLG—atherosclerosis	0.00011	0.000356	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—MAPK3—atherosclerosis	0.000109	0.000353	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—INS—atherosclerosis	0.000108	0.000349	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TNF—atherosclerosis	0.000106	0.000345	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL2—atherosclerosis	0.000106	0.000343	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IGF1—atherosclerosis	0.000104	0.000338	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.000101	0.000328	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SERPINE1—atherosclerosis	9.89e-05	0.000321	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—AKT1—atherosclerosis	9.83e-05	0.000319	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP9—atherosclerosis	9.71e-05	0.000315	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—APOB—atherosclerosis	9.7e-05	0.000314	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—NFKB1—atherosclerosis	9.6e-05	0.000311	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—PPARA—atherosclerosis	9.53e-05	0.000309	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP9—atherosclerosis	9.46e-05	0.000307	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NOS3—atherosclerosis	9.44e-05	0.000306	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—NFKB1—atherosclerosis	9.36e-05	0.000303	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—PPARA—atherosclerosis	9.36e-05	0.000303	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—APOA1—atherosclerosis	8.94e-05	0.00029	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—APOA1—atherosclerosis	8.78e-05	0.000285	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—VEGFA—atherosclerosis	8.71e-05	0.000282	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—STAT3—atherosclerosis	8.63e-05	0.00028	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6—atherosclerosis	8.58e-05	0.000278	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—VEGFA—atherosclerosis	8.5e-05	0.000275	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6—atherosclerosis	8.45e-05	0.000274	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—STAT3—atherosclerosis	8.41e-05	0.000273	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCL8—atherosclerosis	8.38e-05	0.000272	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MAPK3—atherosclerosis	8.24e-05	0.000267	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6—atherosclerosis	8.23e-05	0.000267	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—PPARA—atherosclerosis	8.18e-05	0.000265	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—AKT1—atherosclerosis	8.09e-05	0.000262	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MAPK3—atherosclerosis	8.04e-05	0.00026	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TGFB1—atherosclerosis	8e-05	0.000259	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6—atherosclerosis	7.97e-05	0.000258	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TGFB1—atherosclerosis	7.8e-05	0.000253	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—APOA1—atherosclerosis	7.68e-05	0.000249	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP9—atherosclerosis	7.58e-05	0.000246	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NFKB1—atherosclerosis	7.5e-05	0.000243	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TNF—atherosclerosis	7.47e-05	0.000242	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAPK8—atherosclerosis	7.37e-05	0.000239	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AKT1—atherosclerosis	7.35e-05	0.000238	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TNF—atherosclerosis	7.28e-05	0.000236	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ALB—atherosclerosis	7.08e-05	0.00023	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ALB—atherosclerosis	6.96e-05	0.000225	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VEGFA—atherosclerosis	6.8e-05	0.000221	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—STAT3—atherosclerosis	6.74e-05	0.000218	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAPK3—atherosclerosis	6.44e-05	0.000209	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TGFB1—atherosclerosis	6.25e-05	0.000202	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ALB—atherosclerosis	6.08e-05	0.000197	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6—atherosclerosis	6.03e-05	0.000195	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6—atherosclerosis	5.88e-05	0.00019	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—AKT1—atherosclerosis	5.56e-05	0.00018	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—AKT1—atherosclerosis	5.42e-05	0.000176	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6—atherosclerosis	4.71e-05	0.000153	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AKT1—atherosclerosis	4.34e-05	0.000141	CbGpPWpGaD
